Abstract
The Ia antigen allospecificities of individuals with B type chronic lymphocytic leukemia differed significantly from those of a control population. A monoclonal antibody, IVD12, directed to a MB3-1ike determinant, reacted with 92.5 percent of the individuals with leukemia and yielded the greatest positive relative risk, 13.5. A lower degree of positive association was found with the presence of the MT2 determinant. In contrast, the low observed frequency of the MT1/MB1 determinant among leukemic individuals was associated with the most significant negative relative risk, -8.1. Among HLA- DR specificities, the relative risk associated with the presence of DR5 was positive while that with DR2 was negative.
Full Text
The Full Text of this article is available as a PDF (396.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Burmester G. R., Yu D. T., Irani A. M., Kunkel H. G., Winchester R. J. Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum. 1981 Nov;24(11):1370–1376. doi: 10.1002/art.1780241106. [DOI] [PubMed] [Google Scholar]
- Corte G., Calabi F., Damiani G., Bargellesi A., Tosi R., Sorrentino R. Human Ia molecules carrying DC1 determinants differ in both alpha- and beta-subunits from Ia molecules carrying DR determinants. Nature. 1981 Jul 23;292(5821):357–360. doi: 10.1038/292357a0. [DOI] [PubMed] [Google Scholar]
- Duquesnoy R. J., Marrari M., Annen K. Identification of an HLA-DR-associated system of B-cell alloantigens. Transplant Proc. 1979 Dec;11(4):1757–1760. [PubMed] [Google Scholar]
- Karr R. W., Kannapell C. C., Stein J. A., Fuller T. C., Duquesnoy R. J., Rodey G. E., Mann D. L., Gebel H. M., Schwartz B. D. Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis. J Exp Med. 1982 Aug 1;156(2):652–657. doi: 10.1084/jem.156.2.652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kratzin H., Yang C. Y., Götz H., Pauly E., Kölbel S., Egert G., Thinnes F. P., Wernet P., Altevogt P., Hilschmann N. Primärstruktur menschlicher Histokompatibilitätsantigene der Klasse II. 1. Mitteilung: Aminosäuresequenz der N-terminalen 198 Reste der beta-Kette des HLA-Dw2,2;DR2,2-Alloantigens. Hoppe Seylers Z Physiol Chem. 1981 Dec;362(12):1665–1669. [PubMed] [Google Scholar]
- LILLY F., BOYSE E. A., OLD L. J. GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS. Lancet. 1964 Dec 5;2(7371):1207–1209. doi: 10.1016/s0140-6736(64)91043-8. [DOI] [PubMed] [Google Scholar]
- Nuñez-Roldan A., Martinez-Guibelalde F., Gomez-Garcia P., Gomerz-Pereira C., Nuñez-Ollero G., Torres-Gomez A. Possible HLA role in a family with Hodgkin's disease. Tissue Antigens. 1979 May;13(5):377–378. doi: 10.1111/j.1399-0039.1979.tb00812.x. [DOI] [PubMed] [Google Scholar]
- Shackelford D. A., Mann D. L., van Rood J. J., Ferrara G. B., Strominger J. L. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4566–4570. doi: 10.1073/pnas.78.7.4566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Walford R. L., Smith G. S., Waters H. Histocompatibility systems and disease states with particular reference to cancer. Transplant Rev. 1971;7:78–111. doi: 10.1111/j.1600-065x.1971.tb00464.x. [DOI] [PubMed] [Google Scholar]
- Winchester R. J., Kunkel H. G. The human Ia system. Adv Immunol. 1979;28:221–292. [PubMed] [Google Scholar]
- Winchester R. J., Wernet P., Kunkel H. G., Dupont B., Jersild C., Fu S. M. Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med. 1975 Apr 1;141(4):924–929. [PMC free article] [PubMed] [Google Scholar]